Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study

Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Selda Murat, Hakkı Kaya, Yüksel Çavuşoğlu, Mehmet Birhan Yılmaz
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	KARE Publishing 2021-04-01
Sraith:	Türk Kardiyoloji Derneği Arşivi
Rochtain ar líne:	https://archivestsc.com/jvi.aspx?un=TKDA-58675&volume=49&issue=3

Míreanna comhchosúla

Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction
de réir: Yuksel Cavusoglu, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Management of Hyperkalemia in Heart Failure
de réir: Hakan Altay, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Noncompliance with Dietary Salt Restriction and Outcomes in Chronic Heart Failure: A Propensity Score Matching Analysis from TREAT-HF Registry
de réir: Bihter Senturk, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Arginine vasopressin and difficult triangle of heart failure, atrial fibrillation, and hyponatremia
de réir: Hakki Kaya, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Hyperkalemia in chronic heart failure
de réir: Hakan Altay
Foilsithe / Cruthaithe: (2021-04-01)

2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues
de réir: İbrahim Sarı, et al.
Foilsithe / Cruthaithe: (2016-12-01)

Hematochezia in a Patient with Renal Failure and Hyperkalemia
de réir: Tânia Meira, et al.
Foilsithe / Cruthaithe: (2015-05-01)

Hyperkalemia in Heart Failure: Probably Not O“K”
de réir: Marat Fudim, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy
de réir: Selda Murat, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Vaccination of adults with heart failure and chronic heart conditions: Expert opinion
de réir: Ahmet Çelik, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Relationship between functional capacity and socioeconomic status in a cohort of Turkish heart failure patients
de réir: Hakkı Kaya, et al.
Foilsithe / Cruthaithe: (2016-09-01)

Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction
de réir: Hasan Yucel, et al.
Foilsithe / Cruthaithe: (2015-07-01)

Predictors of Survival in Heart Failure
de réir: Yüksel Çavuşoğlu
Foilsithe / Cruthaithe: (2015-03-01)

C-reactive protein/albumin ratio designates advanced heart failure among outpatients with heart failure
de réir: Oguzhan Yucel, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Hyperkalemia in Diabetes Mellitus Setting
de réir: Kleber Goia-Nishide, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Brain-derived neurotrophic factor in heart failure
de réir: Mehmet Birhan Yılmaz
Foilsithe / Cruthaithe: (2019-11-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
de réir: R. Eschalier, et al.
Foilsithe / Cruthaithe: (2015-09-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
de réir: R. Eschalier, et al.
Foilsithe / Cruthaithe: (2015-09-01)

Hyperkalemia in heart failure patients: current challenges and future prospects
de réir: López-Vilella R, et al.
Foilsithe / Cruthaithe: (2016-02-01)

Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study
de réir: Mehdi Zoghi, et al.
Foilsithe / Cruthaithe: (2016-09-01)

PHYSICAL-TRAINING REDUCES EXERCISE-INDUCED HYPERKALEMIA IN CHRONIC HEART-FAILURE
de réir: Barlow, C, et al.
Foilsithe / Cruthaithe: (1992)

Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry)
de réir: Xuejuan Jin, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Ranolazine Induced Bradycardia, Renal Failure, and Hyperkalemia: A BRASH Syndrome Variant
de réir: Syed Arsalan Akhter Zaidi, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Influences of cardiac resynchronization therapy on cardiac biomarkers in patients with chronic heart failure
de réir: Yüksel Çavuşoğlu
Foilsithe / Cruthaithe: (2018-03-01)

Renal Dysfunction in Patients with Heart Failure
de réir: Jawad K. Manuti
Foilsithe / Cruthaithe: (2010-07-01)

Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?
de réir: Raquel López-Vilella, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Sodium glucose co-transporter 2 inhibitors in heart failure therapy
de réir: Yüksel Çavuşoğlu, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Maintaining the balance between benefits and risks: The example of hyperkalemia in patients with heart failure
de réir: Aldo P. Maggioni
Foilsithe / Cruthaithe: (2020-09-01)

Hyperkalemia-induced complete heart block
de réir: Alireza Baratloo, et al.
Foilsithe / Cruthaithe: (2015-05-01)

Multiparametric Assessment of Right Ventricular Dysfunction in Heart Failure: An Analysis From PARAGON‐HF
de réir: Henri Lu, et al.
Foilsithe / Cruthaithe: (2025-01-01)

How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction?
de réir: Ahmet Çelik, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Guideline for the Use of Natriuretic Peptides in the Early Diagnosis and Management of Heart Failure in Primary Care (Joint Consensus Report by the Eurasian Society of Heart Failure and the Turkish Association of Family Medicine)
de réir: Ahmet Çelik, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Trimethoprim-induced hyperkalemia in renal transplant recipient
de réir: Abhijeet S More, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Autonomic dysfunction in heart failure and renal disease
de réir: Jacqueline Kathleen Phillips
Foilsithe / Cruthaithe: (2012-06-01)

Turkish registry for diagnosis and treatment of acute heart failure: TAKTIK study
de réir: Mehmet Eren, et al.
Foilsithe / Cruthaithe: (2016-12-01)

Trimethoprim/Sulfamethoxazole-Induced Bradycardia, Renal Failure, AV-Node Blockers, Shock and Hyperkalemia Syndrome
de réir: Nnaemeka Diribe, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Representativeness of the PIONEER‐HF and PARAGLIDE‐HF in patients hospitalized with acute heart failure
de réir: Dong‐Yi Chen, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Utilidade da Idade, Creatinina e Fração de Ejeção - Modificação da Dieta no Escore de Doença Renal para Prever a Sobrevivência em Pacientes com Insuficiência Cardíaca
de réir: Rengin Çetin Güvenç, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Cost-of-disease of Heart Failure in Turkey: A Delphi Panel-based Analysis of Direct and Indirect Costs
de réir: Yüksel Çavuşoğlu, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Effect of physical training on exercise-induced hyperkalemia in chronic heart failure. Relation with ventilation and catecholamines.
de réir: Barlow, C, et al.
Foilsithe / Cruthaithe: (1994)